CN100435842C - Chinese-medicinal preparation for treating hypertension and its making method - Google Patents

Chinese-medicinal preparation for treating hypertension and its making method Download PDF

Info

Publication number
CN100435842C
CN100435842C CNB2006100868467A CN200610086846A CN100435842C CN 100435842 C CN100435842 C CN 100435842C CN B2006100868467 A CNB2006100868467 A CN B2006100868467A CN 200610086846 A CN200610086846 A CN 200610086846A CN 100435842 C CN100435842 C CN 100435842C
Authority
CN
China
Prior art keywords
filtrate
preparation
chinese medicine
traditional chinese
ethanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2006100868467A
Other languages
Chinese (zh)
Other versions
CN1895659A (en
Inventor
张丽艳
张光奇
梁光义
杨玉琴
许滔
方玉珍
靳凤云
钟正灵
吴静澜
高言明
李健
郑曙光
任永全
曾万玲
张敬杰
刘毅
张丽丽
田源红
陈新华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guiyang College of Traditional Chinese Medicine
Original Assignee
Guiyang College of Traditional Chinese Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guiyang College of Traditional Chinese Medicine filed Critical Guiyang College of Traditional Chinese Medicine
Priority to CNB2006100868467A priority Critical patent/CN100435842C/en
Publication of CN1895659A publication Critical patent/CN1895659A/en
Application granted granted Critical
Publication of CN100435842C publication Critical patent/CN100435842C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

A Chinese medicine for treating hypertension, dizziness and insomnia is prepared from 6 Chinese-medicinal materials including evodia fruit, ginseng, alismatis rhizome, ginger, etc. Its preparing process is also disclosed.

Description

治疗高血压病的中药制剂及制备方法 Traditional Chinese medicine preparation and preparation method for treating hypertension

技术领域 technical field

本发明涉及一种治疗高血压病的中药制剂及其制备方法,属于中药技术领域。The invention relates to a traditional Chinese medicine preparation for treating hypertension and a preparation method thereof, belonging to the technical field of traditional Chinese medicines.

背景技术 Background technique

高血压病是最常见的心血管疾病,其患病人数众多,约占总死亡人数的42.5%,为人类的第一杀手,其主要临床表现为血压升高。高血压病属慢性病,目前,高血压发病有两大趋势:一是发病率上升,转归严重,最终多死于心脑血管病和肾衰竭;二是发病年龄降低,中青年患者增多。高血压病的预防与治疗已成为心血管领域中最重要的全球性课题之一。Hypertension is the most common cardiovascular disease, with a large number of patients, accounting for about 42.5% of the total death toll. It is the first killer of human beings, and its main clinical manifestation is elevated blood pressure. Hypertension is a chronic disease. At present, there are two major trends in the incidence of hypertension: one is that the incidence rate is increasing, and the outcome is serious, and most of them will eventually die from cardiovascular and cerebrovascular diseases and renal failure; the other is that the age of onset is decreasing, and young and middle-aged patients are increasing. The prevention and treatment of hypertension has become one of the most important global issues in the cardiovascular field.

目前,国内外应用西药治疗高血压疾病的药物品种较多,更新较快,但随着临床和试验研究不断深入,发现这些药物有其自身的一些不足,如药物的作用不够温和,作用的范围过于广泛及副作用较多。随着生活水平的不断提高,人们更加崇尚自然疗法,对医疗保健的质和量提出了更高的要求。因此,寻求新的高效低毒的治疗高血压病的长期使用的药物是十分必要的。经过长期的临床实践,中医学在治疗高血压方面形成了自己独特的理论认识,积累了丰富的经验。我们对高血压的发病规律进行了深入地探讨,认为阴阳失衡,痰浊上泛,是其基本病机,只有审因论治,才能提高疗效。At present, there are many kinds of medicines for the treatment of hypertension with western medicine at home and abroad, and they are updated quickly. However, with the deepening of clinical and experimental research, it is found that these medicines have some shortcomings of their own, such as the effect of the medicine is not mild enough, and the range of action is limited. Too extensive and many side effects. With the continuous improvement of living standards, people are more advocating natural therapy, and put forward higher requirements for the quality and quantity of medical care. Therefore, it is very necessary to seek a new long-term drug for the treatment of hypertension with high efficiency and low toxicity. After long-term clinical practice, Chinese medicine has formed its own unique theoretical understanding and accumulated rich experience in the treatment of hypertension. We have conducted in-depth discussions on the pathogenesis of hypertension, and believe that the imbalance of yin and yang, and the turbidity of phlegm are its basic pathogenesis. Only by examining the cause and treating it can the curative effect be improved.

发明内容 Contents of the invention

本发明的目的在于提供一种治疗高血压病的中药制剂及其制备方法,以解决现有技术存在的问题。The object of the present invention is to provide a traditional Chinese medicine preparation for treating hypertension and a preparation method thereof, so as to solve the problems in the prior art.

本发明的目的通过如下的实施方案实现:The purpose of the present invention is achieved through the following embodiments:

本发明的治疗高血压病的中药制剂,按照重量组分计算,由吴茱萸3-12份,人参3-12份,泽泻3-12份,杜仲10-20份,生姜2-15份和大枣5-20份以及适量的辅料制备而成。The traditional Chinese medicine preparation for treating hypertension of the present invention comprises 3-12 parts of Evodia rutaecarpa, 3-12 parts of ginseng, 3-12 parts of Alisma, 10-20 parts of Eucommia ulmoides, 2-15 parts of ginger and It is prepared from 5-20 parts of jujube and appropriate auxiliary materials.

优选地,本发明的中药制剂用吴茱萸9g,人参9g,泽泻9g,生姜5g,杜仲15g,大枣7g经提取后加适量辅料制备。Preferably, the traditional Chinese medicine preparation of the present invention is prepared by extracting 9g of Evodia rutaecarpa, 9g of ginseng, 9g of Alisma, 5g of ginger, 15g of Eucommia, and 7g of jujube, and adding appropriate amount of auxiliary materials.

所述的中药制剂可以制成颗粒制剂(含:泡腾颗粒)、胶囊制剂(含:硬胶囊制剂、软胶囊制剂)、片剂(含:泡腾片、分散片、控释片、缓释片、口崩片、咀嚼片、舌下含片)或丸剂(含:微丸制剂、滴丸制剂)、口服液制剂。Described Chinese medicine preparation can be made into granule preparation (containing: effervescent granule), capsule preparation (containing: hard capsule preparation, soft capsule preparation), tablet (containing: effervescent tablet, dispersible tablet, controlled-release tablet, slow-release tablet) tablet, orally disintegrating tablet, chewable tablet, sublingual tablet) or pill (including: pellet preparation, drop pill preparation), oral liquid preparation.

所述治疗高血压病的中药制剂的制备方法为:称取原料药材吴茱萸、人参和泽泻,将所述重量配比的吴茱萸、人参和泽泻加8-20倍重量的50-80%(v/v)的乙醇提取1-5次,每1-2小时,滤过,得滤液A,备用;称取厚度为1-8毫米的生姜片、杜仲和大枣,将所述重量配比的生姜片、杜仲和大枣加8-20倍重量水,提取时间1-4小时,共提1-4次,合并煎液,滤过,滤液浓缩至一定的相对密度的清膏,放冷,加乙醇使药液含醇量为50-80%(w/w),静置10-24小时,滤过,得滤液B,将滤液A与滤液B合并,回收乙醇并浓缩至一定密度的稠膏,干燥,粉碎成细粉;加入辅料适量,制备成需要的制剂。The preparation method of the traditional Chinese medicine preparation for treating hypertension is as follows: taking the raw medicinal materials Evodia rutaecarpa, ginseng and Alisma alisma, adding 8-20 times the weight of 50-80% ( v/v) ethanol extraction 1-5 times, every 1-2 hours, filter to get filtrate A, for subsequent use; take ginger slices, Eucommia ulmoides and jujube with a thickness of 1-8 mm, and weigh the Add 8-20 times the weight of water to ginger slices, eucommia and jujube, extract for 1-4 hours, extract 1-4 times in total, combine the decoction, filter, concentrate the filtrate to a clear paste with a certain relative density, and let it cool , add ethanol to make the alcohol content of the medicinal solution be 50-80% (w/w), let stand for 10-24 hours, filter to obtain filtrate B, merge filtrate A and filtrate B, reclaim ethanol and concentrate to a certain density Thick paste, dried, crushed into fine powder; adding appropriate amount of auxiliary materials to prepare the desired preparation.

本发明优选的制备方法为:称取原料药吴茱萸9g、人参9g和泽泻9g加8-20倍重量的50-80%(v/v)的乙醇提取1-5次,每1-2小时,滤过,得滤液A,备用;将切成厚度为1-3毫米的生姜片5g、杜仲15g和大枣7g加8-20倍重量水,提取时间1-4小时,共提1-4次,合并煎液,滤过,滤液浓缩至一定的相对密度的清膏,放冷,加乙醇使药液含醇量为50-80%(w/w),静置10-24小时,滤过,得滤液B,将滤液A与滤液B合并,回收乙醇并浓缩至一定密度的稠膏,干燥,粉碎成细粉;加入辅料适量,混匀,制成颗粒1000g,即得颗粒剂。The preferred preparation method of the present invention is as follows: Weigh 9 g of raw materials Evodia rutaecarpa, 9 g of ginseng and 9 g of Alisma, add 8-20 times the weight of 50-80% (v/v) ethanol and extract 1-5 times, every 1-2 hours , filtered to get the filtrate A, for subsequent use; 5g of ginger slices, 15g of Eucommia ulmoides and 7g of jujube, which are cut into 1-3 mm in thickness, are added with 8-20 times the weight of water, and the extraction time is 1-4 hours, and 1-4 Second, combine the decoction, filter, and the filtrate is concentrated to a certain relative density clear paste, let cool, add ethanol to make the alcohol content of the medicinal solution be 50-80% (w/w), leave standstill for 10-24 hours, filter After filtering, the filtrate B is obtained, the filtrate A and the filtrate B are combined, the ethanol is recovered and concentrated to a thick paste of a certain density, dried, and pulverized into a fine powder; an appropriate amount of auxiliary materials is added, mixed evenly, and 1000 g of granules are made to obtain granules.

本发明的中药制剂中使用的辅料是中药制药领域中的常规辅料,辅料的具体种类和使用量根据具体的剂型确定,本领域的普通技术人员根据需要制备的剂型,容易确定使用的辅料及其用量。The adjuvant used in the traditional Chinese medicine preparation of the present invention is a conventional adjuvant in the field of traditional Chinese medicine pharmacy. The specific type and usage amount of the adjuvant are determined according to the specific dosage form. Those of ordinary skill in the art can easily determine the adjuvant used and the dosage form prepared according to the needs. Dosage.

本发明的中药制剂具有调肝泻浊,降压固本的功效,主要用于阴阳失衡,痰浊上泛,厥阴痰浊的眩晕头疼、失眠等症候,常用于高血压病的治疗,与现有技术相比,其毒副作用小、治疗效果好且制备简单,服用、携带方便。The traditional Chinese medicine preparation of the present invention has the effects of regulating the liver and purging turbidity, lowering blood pressure and consolidating the foundation, and is mainly used for symptoms such as yin and yang imbalance, panting of phlegm turbidity, dizziness, headache and insomnia caused by Jueyin phlegm turbidity, and is commonly used in the treatment of hypertension. Compared with the prior art, the invention has less toxic and side effects, better therapeutic effect, simple preparation, and is convenient to take and carry.

本发明是以吴茱萸为君药,同时结合高血压病的病理、病机之特点,配以调肝泻浊,降压固本的中药共同组成的方剂。The present invention is a prescription composed of Evodia rutaecarpa as the king drug, combined with the characteristics of pathology and pathogenesis of hypertension, and combined with traditional Chinese medicines for regulating the liver, purging turbidity, lowering blood pressure and strengthening the root.

方中以吴茱萸为君药:吴茱萸味苦性温,归肝、脾、胃、肾经,具有散寒止痛、降逆止呕、助阳止泻之功。从功能上看,其辛升苦降,升降气机,疏肝开郁,又性属燥热,可温中散寒,燥湿化痰,且其性下行而散,能下气平冲,降浊止逆,温化通降。现代药理学研究证实,吴茱萸具有镇痛、安神、抗菌、降压和抗氧化等药理作用。且吴茱萸贵州五大名药之一,故取用之为君药。In the prescription, Evodia rutaecarpa is used as the king drug: Evodia rutaecarpa is bitter in taste and warm in nature, and it returns to the liver, spleen, stomach, and kidney meridian. From the point of view of function, its acrimony enhances bitterness, lowers qi, soothes the liver and relieves stagnation. Turbidity stops reverse, warming and descending. Modern pharmacological studies have confirmed that Evodia rutaecarpa has pharmacological effects such as analgesia, tranquilization, antibacterial, antihypertensive and anti-oxidation. And Evodia rutaecarpa is one of the five famous medicines in Guizhou, so it is taken as the king medicine.

方中配以人参为臣药:人参味甘微苦、性微温,具有益气补虚之功。从功能上看,其性味多甘,能补益脏腑之气。现代药理学研究发现,人参具有抗休克,降低血糖,增强机体免疫功能等作用。在方中与吴茱萸相配伍,有益气补虚的作用,并增强吴茱萸温化通降,培元降压之功,故为臣药。Ginseng is used as a minister drug in the prescription: Ginseng is sweet and slightly bitter, slightly warm in nature, and has the function of nourishing qi and tonifying deficiency. From a functional point of view, its nature and flavor are sweet, which can nourish the qi of the viscera. Modern pharmacological studies have found that ginseng has the effects of anti-shock, lowering blood sugar, and enhancing the immune function of the body. Compatible with Evodia rutaecarpa in the prescription, it has the effect of benefiting qi and tonifying deficiency, and enhances the effect of Evodia rutaecarpa on warming, reducing blood pressure, nourishing yuan and lowering blood pressure, so it is a ministerial drug.

用泽泻、杜仲、生姜共为佐药:因泽泻性寒,味甘淡,有利水渗湿,泻热的功效;杜仲,性温味甘,归肝、肾经,能补肝肾,强盘骨;生姜,味微辛性,具温中散寒,温肺止咳之功。三味为佐药,实取泽泻的泻浊利湿,杜仲之补肾培元降压,生姜温中降逆之功,共助吴茱萸降压之力。Use Alisma, Eucommia, and Ginger as adjuvant drugs: Alisma is cold in nature, sweet and light in taste, diuretic and damp, and has the effect of purging heat; Eucommia, warm in nature and sweet in taste, returns to the liver and kidney meridian, can nourish the liver and kidney, Strong pangu; Ginger, slightly pungent in taste, has the functions of warming the middle and dispelling cold, warming the lungs and relieving cough. The three flavors are adjuvant medicines, which actually take Alisma diarrhea for purging turbidity and dampness, Eucommia for nourishing the kidney and nourishing the essence to lower blood pressure, and ginger for warming the middle and reducing adverse effects, and together help Evodia rutaecarpa to lower blood pressure.

用大枣为使药:大枣性温味甘,能缓和药性,具有调补脾胃,调和诸药之功,且用其为使,可助人参健脾益气补虚之功。Use jujube as an envoy: jujube is warm and sweet in nature, can moderate the properties of the medicine, has the function of regulating the spleen and stomach, and reconciling various medicines, and using it as an envoy can help ginseng invigorate the spleen, replenish qi and invigorate deficiency.

纵观全方,具有调补与泻浊相结合的特点,体现了中医治疗高血压病的病机‘虚’、‘痰’、‘逆’,虚为脾胃,也重肾虚,痰(湿)为痰(湿)浊中阻,‘逆’为阴阳失调,肝失条达,气机逆乱,及治则“治疗应以‘扶土抑木,平逆固本’,扶土就是补脾虚除脾湿,具体就是调肝泻浊,固本降压”。故能有效地治疗阴阳失衡,痰浊上泛,厥阴痰浊引起的高血压病症。Looking at the whole prescription, it has the characteristics of combining tonifying and purging turbidity, reflecting the pathogenesis of TCM treatment of hypertension, "deficiency", "phlegm", and "reversal". Deficiency is the spleen and stomach, and it also emphasizes kidney deficiency. It refers to obstruction of phlegm (dampness) turbidity, and 'Ni' refers to imbalance of yin and yang, liver disorder, and qi mechanism reversed. To remove spleen dampness, specifically, it regulates the liver, purifies the turbidity, strengthens the root and lowers blood pressure." Therefore, it can effectively treat the imbalance of yin and yang, the panting of phlegm turbidity, and the hypertension caused by Jueyin phlegm turbidity.

吴茱萸中主要含有挥发油、生物碱等成分,其生物碱中的主要成分吴茱萸碱、吴茱萸次碱有镇痛、降压及等药理作用。Evodia rutaecarpa mainly contains volatile oil, alkaloids and other components. The main components of the alkaloids are evodiamine and evodiamine, which have pharmacological effects such as analgesia, antihypertensive and antihypertensive.

人参主要含有皂苷、多糖、微量元素等成分。其中人参皂苷是人参主要活性成分,常用于气虚欲脱,脉微欲绝,肺气虚弱,气血亏虚,血虚证等。Ginseng mainly contains saponins, polysaccharides, trace elements and other components. Among them, ginsenoside is the main active ingredient of ginseng, which is commonly used for qi deficiency, faint pulse, weak lung qi, deficiency of qi and blood, and blood deficiency syndrome.

泽泻主要含有三萜类、倍半萜类及二萜类化合物等脂溶性成分,现代药理研究表明,泽泻有抑制动脉硬化、降血脂、利尿、降血压、抗脂肪肝等作用;同时,大量现代临床资料也表明,泽泻及其复方在高血压、高血脂等常见病的治疗上均取得了良好的疗效。Alisma mainly contains fat-soluble components such as triterpenoids, sesquiterpenoids and diterpenoids. Modern pharmacological studies have shown that Alisma has the effects of inhibiting arteriosclerosis, lowering blood fat, diuresis, lowering blood pressure, and anti-fatty liver; at the same time, A large number of modern clinical data also show that Alisma and its compound have achieved good curative effects in the treatment of common diseases such as hypertension and hyperlipidemia.

生姜主要有效成分为挥发油、姜辣素、二苯基庚烷等成分。具有发汗解表,温中止呕,温肺止咳之功。The main active ingredients of ginger are volatile oil, gingerol, diphenylheptane and other components. It has the effects of sweating to relieve the exterior, warming the middle and relieving vomiting, warming the lungs and relieving cough.

杜仲主要含生物碱,木脂素,环烯醚萜类,黄酮类等成分,其中松脂醇二葡萄糖苷和丁香脂二葡萄糖苷,有明显的降压作用;Ivioden-drin,Asperoside和丁香脂素是血管紧张素和环腺昔酸(CAMP)的抑制剂,故可以扩张血管,增加冠状动脉血流量。现代药理学试验也证明了杜仲水提物对犬有明显的降压作用,而且疗效稳定,无毒副作用。Eucommia mainly contains alkaloids, lignans, iridoids, flavonoids and other components, among which pinoresinol diglucoside and syringalis diglucoside have obvious antihypertensive effect; Ivioden-drin, Asperoside and syringaresin It is an inhibitor of angiotensin and cyclic adenosylic acid (CAMP), so it can dilate blood vessels and increase coronary blood flow. Modern pharmacological experiments have also proved that the water extract of Eucommia ulmoides has obvious antihypertensive effect on dogs, and the curative effect is stable, without toxic and side effects.

大枣含有黄酮类、多种氨基酸、糖类等水溶性成分。大枣煎剂可提高小鼠体重、延长负荷游泳时间,其所含的黄酮类的成分具有明显地镇静、催眠、降血压作用。Jujube contains flavonoids, various amino acids, sugars and other water-soluble components. Jujube decoction can increase the weight of mice and prolong the swimming time under load. The flavonoids contained in it have obvious sedative, hypnotic and blood pressure-lowering effects.

为完成本发明,我们使用本发明的吴茱萸制剂提取物(即:本发明实施例1制备得到的本发明复方提取物)进行了一系列的实验研究,其结果如下:In order to complete the present invention, we have carried out a series of experimental studies using the Evodia rutaecarpa preparation extract of the present invention (that is: the compound extract of the present invention prepared in Example 1 of the present invention), and the results are as follows:

药理、毒理部分:Pharmacology and Toxicology:

主要药效学研究:Main pharmacodynamic studies:

对正常大鼠血压和心率的影响试验结果表明:The test results of the influence on blood pressure and heart rate of normal rats showed that:

经十二指肠给药后,吴茱萸制剂提取物大剂量组(2.0g/kg)给药后30min即具明显降压作用,60min产生最大效应,大鼠正常收缩压和舒张压分别下降17%和20%,与给药前比较具有显著差异(P<0.05,P<0.01),降压同时可使心率减慢,与给药前比较有显著差异(P<0.05)。中剂量组(1.0g/kg)给药后45min亦明显降压,90min产生最大效应,SAP与DAP分别降低19%与14%,与给药前比较差异显著(P<0.05,P<0.01),降压作用持续时间4h以上。与等剂量复方罗布麻组作用相似。对HR无明显影响。After administration through the duodenum, the high-dose Evodia rutaecarpa extract group (2.0g/kg) had a significant antihypertensive effect 30 minutes after administration, and produced the maximum effect at 60 minutes. The normal systolic blood pressure and diastolic blood pressure of rats decreased by 17% respectively and 20%, compared with before administration, there is a significant difference (P<0.05, P<0.01), blood pressure can also slow down the heart rate, compared with before administration, there is a significant difference (P<0.05). The middle dose group (1.0g/kg) also significantly lowered blood pressure 45 minutes after administration, and produced the maximum effect at 90 minutes. SAP and DAP were respectively reduced by 19% and 14%, which were significantly different from those before administration (P<0.05, P<0.01) , The duration of antihypertensive effect is more than 4h. The effect is similar to that of the compound apocynum group with equal doses. No significant effect on HR.

对清醒肾性高血压大鼠血压的影响试验结果表明:The test results of the influence on the blood pressure of conscious renal hypertensive rats show that:

经灌胃给予吴茱萸制剂提取物:大剂量组(2.0g/kg)降低收缩压与舒张压的作用与给药前比较,差异显著(P<0.05);中剂量组(1.0g/kg)给药当日即见明显降压效应,收缩压与舒张压降低幅度与药前比较分别为25%与35%,差异显著(P<0.01),收缩压的降低作用与等剂量复方罗布麻组相似,舒张压降低效应强于复方罗布麻组,且该组停药9天,血压组未回复至给药前;各组对清醒肾性高血压大鼠心率均无明显的影响。The extract of Evodia rutaecarpa preparation was administered by intragastric administration: the effect of reducing systolic blood pressure and diastolic blood pressure in the high-dose group (2.0g/kg) was significantly different from that before administration (P<0.05); the middle-dose group (1.0g/kg) was given The obvious antihypertensive effect was seen on the same day of the medicine, and the systolic blood pressure and diastolic blood pressure decreased by 25% and 35% compared with before the medicine, and the difference was significant (P<0.01). The diastolic blood pressure lowering effect was stronger than that of the compound apocynum group, and the blood pressure group did not return to before the administration for 9 days after drug withdrawal in this group; each group had no significant effect on the heart rate of conscious renal hypertensive rats.

镇痛作用观察:Observation of analgesic effect:

对小鼠热板致痛的影响试验结果显示,吴茱萸制剂提取物大剂量组无论给药3天或6天,均可延长热板致小鼠舔后足的时间,与空白对照组比较痛阈值显著提高(P<0.05)。对小鼠醋酸致痛的影响试验结果表明,吴茱萸制剂提取物大剂量组与中剂量组对冰醋酸致痛的小鼠扭体反应次数明显减少,与空白对照组比较差异显著(P<0.05)。The test results of the effect on the pain induced by hot plate in mice showed that the high-dose Evodia rutaecarpa extract group could prolong the licking time of mice induced by hot plate no matter whether it was given for 3 days or 6 days, and the pain threshold was compared with that of the blank control group. Significantly increased (P<0.05). The results of the experiment on the effect of acetic acid-induced pain on mice showed that the high-dose and medium-dose groups of Evodia rutaecarpa extract significantly reduced the number of writhing reactions of mice induced by glacial acetic acid, and the difference was significant compared with the blank control group (P<0.05) .

镇静催眠作用观察试验:Sedative and hypnotic effect observation test:

对小鼠戊巴比妥钠阈下催眠量的影响试验结果表明,吴茱萸制剂提取物三个剂量组单次或连续给药3天,对阈下剂量戊巴比妥钠对小鼠的催眠作用无影响。对小鼠戊巴比妥钠催眠量的观察试验结果显示,连续给药3天,吴茱萸制剂提取物小剂量组对催眠剂量戊巴比妥钠引起的小鼠睡眠有协同作用,与空白对照组比较,小鼠睡眠持续时间显著延长(P<0.05)。The test results of the effect on the subthreshold hypnotic dose of pentobarbital sodium in mice showed that the three dosage groups of Evodia rutaecarpa preparations were administered for a single time or continuously for 3 days, and had no effect on the hypnotic effect of subthreshold dose pentobarbital sodium on mice. no effect. The results of the observation test on the hypnotic dose of pentobarbital sodium in mice showed that after continuous administration for 3 days, the low-dose group of Evodia rutaecarpa preparation had a synergistic effect on the sleep induced by the hypnotic dose of pentobarbital sodium in mice, which was comparable to that of the blank control group. In comparison, the sleep duration of mice was significantly prolonged (P<0.05).

对小鼠自发活动的影响试验表明:Experiments on the effect on the spontaneous activity of mice showed that:

连续给药3天,吴茱萸制剂提取物小剂量组可使小鼠自发活动明显减少,与空白对照差异显著(P<0.05)。After continuous administration for 3 days, the low-dose Evodia rutaecarpa extract group can significantly reduce the spontaneous activity of the mice, which is significantly different from the blank control group (P<0.05).

药效学试验结果表明:可降低正常(麻醉)大鼠血压(SAP与DAP)、降压的同时使大鼠心率减慢;对清醒肾性高血压大鼠降压(SAP与DAP)作用显著而稳定,尤其中剂量组、降低DAP作用较之等剂量的降压药复方罗布麻作用更稳定,停药9天仍保持原有降压药效。本次药效研究还证实:该药可提高小鼠对热板致痛的痛阈值,抑制醋酸引起的扭体反应,延长催眠剂量的戊巴比妥钠引起的小鼠持续睡眠时间,减少小鼠自发活动的次数,说明该药对缓解高血压病的症状有一定的辅助作用。The results of pharmacodynamic tests show that it can reduce the blood pressure (SAP and DAP) of normal (anesthetized) rats, and slow down the heart rate of rats while lowering blood pressure; it has a significant effect on reducing blood pressure (SAP and DAP) in conscious renal hypertensive rats And stable, especially in the middle-dose group, the effect of reducing DAP is more stable than that of the antihypertensive drug compound apocynum of the same dose, and the original antihypertensive drug effect is still maintained for 9 days after drug withdrawal. The pharmacodynamic study also confirmed that the drug can increase the pain threshold of mice to pain caused by hot plates, inhibit the writhing response caused by acetic acid, prolong the duration of sleep in mice induced by a hypnotic dose of pentobarbital sodium, and reduce The number of spontaneous activities of the mice shows that the drug has a certain auxiliary effect on alleviating the symptoms of hypertension.

此研究结果表明:本发明复方吴茱萸制剂降压效果明显而稳定,具有良好的开发前景和临床应用价值。The results of this study show that the compound Evodia rutaecarpa preparation of the present invention has obvious and stable antihypertensive effect, and has good development prospects and clinical application value.

急性毒性研究:Acute Toxicity Study:

本品以最大浓度(60%),最大容积(0.5ml/10g/日)在24小时内分2次灌胃(0.25ml/10g/次)后,连续观察7天,结果,40只实验小鼠未见死亡和明显中毒表现,7天后体重显著增加(P<0.001),本品成人临床用量为:8g浸膏粉/日,每只小鼠耐受量为:0.614g,小鼠平均体重:20.45g,经计算小鼠最大耐受量为:187.5倍。This product is with the maximum concentration (60%), the maximum volume (0.5ml/10g/day) in 24 hours after 2 times of intragastric administration (0.25ml/10g/time), continuous observation for 7 days, as a result, 40 experimental small No death or obvious poisoning was seen in the mice, and the body weight increased significantly after 7 days (P<0.001). The adult clinical dosage of this product is: 8g extract powder/day, and the tolerance dose of each mouse is: 0.614g, the average weight of mice : 20.45g, the calculated maximum tolerated dose of mice is: 187.5 times.

药学部分:Pharmacy Section:

本发明的处方工艺路线的确定是在查阅国内外中医药现代研究文献的基础上,根据该处方的功能主治和处方中各药所含有效成分的理化性质,制定了以醇提+水提醇沉的制备工艺。并对该工艺进行正交试验优选:The determination of the prescription process route of the present invention is on the basis of consulting the modern research literature of traditional Chinese medicine at home and abroad, according to the functions and indications of the prescription and the physicochemical properties of the active ingredients contained in the prescription, formulate the method of extracting alcohol with alcohol + water. Shen's preparation process. And carry out orthogonal experiment optimization to this process:

1、醇提工艺:按处方比例分别称取吴茱萸、人参、泽泻药材,按正交表L9(34)进行优选。以吴茱萸总碱的总量为指标,对乙醇浓度、乙醇用量、提取时间、提取次数四个因素进行了优化考察,优选出最佳醇提工艺。1. Alcohol extraction process: Weigh the medicinal materials of Evodia rutaecarpa, ginseng and Alisma respectively according to the prescription ratio, and optimize according to the orthogonal table L 9 (3 4 ). Taking the total alkaloids of Evodia rutaecarpa as an index, the four factors of ethanol concentration, ethanol dosage, extraction time and extraction times were optimized and investigated, and the best alcohol extraction process was selected.

2、水提醇沉工艺:按处方比例分别称取杜仲、大枣、生姜片,按正交表L9(34)进行正交试验,以绿原酸总量为指标对加水量、煎煮时间、煎煮次数三个因素进行了优化考察,优选出最佳水煎煮工艺;为了最大限度地去除中药水提液中无效成分,尽可能地保留有效成分,处方比例分别称取杜仲、大枣、生姜片,按上述水煎煮工艺确定的最佳条件提取,提取液浓缩至相应的密度后,按正交表L9(34)进行正交试验以绿原酸总量为指标,对浸膏相对密度、醇沉条件两个因素进行优选,优选出最佳醇沉工艺。最后进行了制粒方法的选择,辅料类型及用量的确定,并对制得颗粒的物理性质进行测定,确定了制剂处方和制法,经中试放大试验证明工艺简单易行、可操作性强,适应大生产的要求。2. Water extraction and alcohol precipitation process: Weigh Eucommia ulmoides, jujube, and ginger slices according to the proportion of the prescription, conduct an orthogonal test according to the orthogonal table L 9 (3 4 ), use the total amount of chlorogenic acid as an index to compare the amount of water added, decocted The three factors of boiling time and decoction times were optimized and investigated, and the best water decoction process was selected; in order to remove the ineffective components in the water extract of traditional Chinese medicine as much as possible and retain the active components as much as possible, the proportion of the prescription was weighed respectively. , jujube, and ginger slices were extracted according to the optimal conditions determined by the above-mentioned water decoction process. After the extract was concentrated to the corresponding density, the orthogonal test was carried out according to the orthogonal table L 9 (3 4 ) and the total amount of chlorogenic acid was Index, optimize the two factors of extract relative density and alcohol precipitation conditions, and optimize the best alcohol precipitation process. Finally, the selection of the granulation method, the determination of the type and dosage of the excipients, and the determination of the physical properties of the granules were carried out, and the formulation and preparation method were determined. The pilot scale-up test proved that the process is simple and easy to operate, and the operability is strong. , to meet the requirements of mass production.

按照《中国药典》2005年版一部附录IC颗粒剂项下的有关要求和《药品注册管理办法》的规定,并进行了大量文献检索,在此基础上制定了本发明临床试验用药品质量标准(草案)及起草说明。According to " Chinese Pharmacopoeia " 2005 edition one appendix IC granule item relevant requirement and " drug registration management method " regulation, and carried out a large amount of document searches, formulated clinical trial drug quality standard of the present invention on this basis ( draft) and drafting instructions.

采用薄层色谱法对本品中人参、泽泻、吴茱萸、大枣进行了定性鉴别,其中以吴茱萸碱和吴茱萸次碱对照品为对照鉴别吴茱萸,以齐墩果酸对照品为对照鉴别大枣,以人参对照药材、人参皂苷Rb1、人参皂苷Rg1、人参皂苷Re对照品为对照鉴别人参,以泽泻对照药材为对照鉴别泽泻。结果表明三批样品(批号分别为:050301、050302、050303)均在与对照品或对照药材色谱相应的位置上显相同颜色的斑点或荧光斑点,阴性均无干扰。Ginseng, Alisma, Evodia, and Jujube in this product were qualitatively identified by thin-layer chromatography. Evodiamine and Evodiamine reference substances were used as controls to identify Evodia rutaecarpa, and oleanolic acid reference substances were used as controls to identify Jujube , using ginseng reference materials, ginsenoside Rb1, ginsenoside Rg1, and ginsenoside Re reference substances as controls to identify ginseng, and Alisma control materials as controls to identify Alisma. The results showed that three batches of samples (batch numbers: 050301, 050302, and 050303) all showed spots or fluorescent spots of the same color at positions corresponding to the chromatogram of the reference substance or the reference medicinal material, and there was no interference in the negative.

参照《中国药典》2005年版一部第118页吴茱萸项下含量测定的方法,并参照高效液相色谱法《中国药典》2005年版一部附录VID,对本品中的吴茱萸总碱的含量进行了测定,经方法学系统考察和三批样品(批号分别为:050301、050302、050303)的含量测定,本品中吴茱萸碱和吴茱萸次碱与其他成分分离良好,吴茱萸次碱在0.3280~1.640ug、吴茱萸碱0.2360~1.180ug范围内线性良好,吴茱萸碱平均加样回收率为101.19%,RSD=1.01%;吴茱萸次碱平均加样回收率为101.19%,RSD=1.31%。结果表明:此方法简便、快速、专属、灵敏、准确。同时确定了本颗粒剂的各项指标均符合《中国药典》2005年版一部附录IC颗粒剂项下的有关规定。With reference to the method of content determination under the item of Evodia rutaecarpa on page 118 of the 2005 edition of "Chinese Pharmacopoeia", and referring to the high-performance liquid chromatography "Chinese Pharmacopoeia" 2005 edition of an appendix VID, the content of the total alkaloids of Evodia rutaecarpa in this product was determined. Determination, through the methodological system investigation and the content determination of three batches of samples (batch numbers: 050301, 050302, 050303 respectively), the evodiamine and evodiamine in this product are well separated from other components, and the evodiamine is 0.3280~1.640ug, The linearity of evodiamine was good in the range of 0.2360-1.180ug. The average recovery rate of evodiamine was 101.19%, RSD=1.01%. The average recovery rate of evodiamine was 101.19%, RSD=1.31%. The results show that this method is simple, rapid, specific, sensitive and accurate. At the same time, it has been determined that each index of the granule meets the relevant regulations under the item of Appendix I granule of "Chinese Pharmacopoeia" 2005 edition.

结果表明:本标准稳定易行,可控性强,重复性好,能够控制本品的质量。The results show that this standard is stable and easy to implement, with strong controllability and good repeatability, and can control the quality of this product.

由以上药学部分的研究结果表明:本发明的工艺合理可行,质量稳定可控。The research results of the above pharmacy part show that the process of the present invention is reasonable and feasible, and the quality is stable and controllable.

具体实施方式: Detailed ways:

下面通过实施例进一步说明本发明。应该理解的是,本发明的实施例是用于说明本发明而不是对本发明的限制。根据本发明的实质对本发明进行的简单改进都属于本发明要求保护的范围。另外,在本发明中,(v/v)表示体积比浓度或者体积比;(w/w)表示重量比浓度或者重量比;(min)表示分钟。除非另有说明,本发明的百分数是重量百分数。The present invention is further illustrated below by way of examples. It should be understood that the embodiments of the present invention are used to illustrate the present invention rather than limit the present invention. The simple improvements made to the present invention according to the essence of the present invention all belong to the protection scope of the present invention. In addition, in the present invention, (v/v) represents volume specific concentration or volume ratio; (w/w) represents weight specific concentration or weight ratio; (min) represents minute. Percentages in this invention are by weight unless otherwise indicated.

实施例1:制备本发明复方提取物及其颗粒剂Embodiment 1: Preparation of compound extract of the present invention and granules thereof

称取原料药材吴茱萸9g、人参9g、泽泻9g,将所述重量配比的吴茱萸、人参、泽泻三味加10倍重量70%(v/v)的乙醇提取二次,每次1.5小时,滤过,合并滤液,得滤液A备用;称取厚度为2mm的生姜片5g、杜仲15g、大枣7g,将所述重量配比的厚度为2mm的生姜片、杜仲、大枣加10倍重量水煎煮二次,每次1.5小时,合并煎液,滤过,滤液浓缩至相对密度为1.05-1.10(60℃),加入乙醇使含醇量为70%(w/w),静置过夜,滤过,得滤液B,将滤液B与滤液A合并,回收乙醇并浓缩至60℃时测相对密度为1.20-1.25的稠膏,减压干燥,粉碎成细粉,得到本发明复方提取物;加入糊精,糖粉适量,混匀,干燥制粒,制成颗粒1000g,即得颗粒剂。本产品开水冲服,一次一袋,一日三次。Weigh 9 g of raw materials Evodia rutaecarpa, 9 g of ginseng, and 9 g of Alisma, and extract twice with ethanol of 10 times the weight of 70% (v/v) of Evodia rutaecarpa, ginseng, and Alisma eczema in the weight ratio, each time for 1.5 hours, Filtrate and combine the filtrates to obtain filtrate A for subsequent use; take 5 g of ginger slices, 15 g of Eucommia ulmoides, and 7 g of jujube with a thickness of 2 mm, and add 10 times the weight of ginger slices, eucommia ulmoides, and jujube with a thickness of 2 mm in the weight ratio Decoct in water twice, 1.5 hours each time, combine the decoction, filter, concentrate the filtrate to a relative density of 1.05-1.10 (60°C), add ethanol to make the alcohol content 70% (w/w), and let stand overnight , filtered to obtain filtrate B, combined filtrate B and filtrate A, reclaimed ethanol and concentrated to 60°C to measure a thick paste with a relative density of 1.20-1.25, dried under reduced pressure, crushed into fine powder, and obtained the compound extract of the present invention Add dextrin and appropriate amount of powdered sugar, mix well, dry and granulate, and make 1000g of granules to obtain granules. Take this product with boiling water, one bag at a time, three times a day.

实施例2:制备本发明复方提取物及其胶囊剂Embodiment 2: preparation compound extract of the present invention and capsule thereof

称取原料药材吴茱萸9g、人参9g、泽泻9g,将所述重量配比的吴茱萸、人参、泽泻三味加10倍重量70%(v/v)的乙醇提取二次,每次1.5小时,滤过,合并滤液,得滤液A,备用;称取厚度为2mm的生姜片5g、杜仲15g、大枣7g,将所述重量配比的厚度为2mm的生姜片、杜仲、大枣加10倍重量水煎煮二次,每次1.5小时,合并煎液,滤过,滤液浓缩至相对密度为1.05-1.10(60℃),加入乙醇使含醇量为70%(w/w),静置过夜,滤过,得滤液B,将滤液B与滤液A合并,回收乙醇并浓缩至60℃时测相对密度为1.20-1.25的稠膏,干燥,粉碎成细粉或加入适量羧甲基纤维素钠,加水湿润制粒,混匀,装入胶囊,即得胶囊剂。Weigh 9 g of raw materials Evodia rutaecarpa, 9 g of ginseng, and 9 g of Alisma, and extract twice with ethanol of 10 times the weight of 70% (v/v) of Evodia rutaecarpa, ginseng, and Alisma eczema in the weight ratio, each time for 1.5 hours, Filtrate and combine the filtrates to obtain filtrate A, which is set aside; take 5 g of ginger slices, 15 g of eucommia ulmoides, and 7 g of jujube with a thickness of 2 mm, and add 10 times the thickness of ginger slices, eucommia ulmoides, and jujube with a thickness of 2 mm in the weight ratio. Decoct in heavy water twice, each time for 1.5 hours, combine the decoction, filter, concentrate the filtrate to a relative density of 1.05-1.10 (60°C), add ethanol to make the alcohol content 70% (w/w), let it stand Overnight, filter to get filtrate B, combine filtrate B and filtrate A, recover ethanol and concentrate to 60°C to measure thick paste with relative density of 1.20-1.25, dry, grind into fine powder or add appropriate amount of carboxymethyl cellulose Sodium, add water to moisten the granules, mix well, put into capsules, and obtain capsules.

实施例3:制备本发明复方提取物及其片剂Embodiment 3: preparation compound extract of the present invention and tablet thereof

称取原料药材吴茱萸9g、人参9g、泽泻9g,将所述重量配比的吴茱萸、人参、泽泻三味加10倍重量70%(v/v)的乙醇提取二次,每次1.5小时,滤过,合并滤液,得滤液A,备用;称取厚度为2mm的生姜片5g、杜仲15g、大枣7g,将所述重量配比的厚度为2mm的生姜片、杜仲、大枣加10倍重量水煎煮二次,每次1.5小时,合并煎液,滤过,滤液浓缩至相对密度为1.05-1.10(60℃),加入乙醇使含醇量为70%(w/w),静置过夜,滤过,得滤液B,将滤液B与滤液A合并,回收乙醇并浓缩至60℃时测相对密度为1.20-1.25的稠膏,干燥,粉碎成细粉;加入适量羧甲基纤维素钠,加水湿润制粒,干燥,压片,即得片剂。Weigh 9 g of raw materials Evodia rutaecarpa, 9 g of ginseng, and 9 g of Alisma, and extract twice with ethanol of 10 times the weight of 70% (v/v) of Evodia rutaecarpa, ginseng, and Alisma eczema in the weight ratio, each time for 1.5 hours, Filtrate and combine the filtrates to obtain filtrate A, which is set aside; take 5 g of ginger slices, 15 g of eucommia ulmoides, and 7 g of jujube with a thickness of 2 mm, and add 10 times the thickness of ginger slices, eucommia ulmoides, and jujube with a thickness of 2 mm in the weight ratio. Decoct in heavy water twice, each time for 1.5 hours, combine the decoction, filter, concentrate the filtrate to a relative density of 1.05-1.10 (60°C), add ethanol to make the alcohol content 70% (w/w), let it stand Overnight, filter to obtain filtrate B, combine filtrate B and filtrate A, recover ethanol and concentrate to 60°C to measure a thick paste with a relative density of 1.20-1.25, dry, grind into fine powder; add appropriate amount of carboxymethyl cellulose Sodium, add water to moisten the granules, dry, compress into tablets, and obtain tablets.

实施例4:制备本发明复方提取物及其口服液Embodiment 4: Preparation of compound extract of the present invention and oral liquid thereof

称取原料药材吴茱萸9g、人参9g、泽泻9g,将所述重量配比的吴茱萸、人参、泽泻三味加10倍重量70%(v/v)的乙醇提取二次,每次1.5小时,滤过,合并滤液,得滤液A,备用;称取厚度为2mm的生姜片5g、杜仲15g、大枣7g,将所述重量配比的厚度为2mm的生姜片、杜仲、大枣加10倍重量水煎煮二次,每次1.5小时,合并煎液,滤过,滤液浓缩至相对密度为1.05-1.10(60℃),加入乙醇使含醇量为70%(w/w),静置过夜,滤过,得滤液B,将滤液B与滤液A合并,回收乙醇并浓缩至适量,加入防腐剂及娇味剂适量,调节总量至1000ml,搅匀,滤过,灌装,灭菌,即得口服液。Weigh 9 g of raw materials Evodia rutaecarpa, 9 g of ginseng, and 9 g of Alisma, and extract twice with ethanol of 10 times the weight of 70% (v/v) of Evodia rutaecarpa, ginseng, and Alisma eczema in the weight ratio, each time for 1.5 hours, Filtrate and combine the filtrates to obtain filtrate A, which is set aside; take 5 g of ginger slices, 15 g of eucommia ulmoides, and 7 g of jujube with a thickness of 2 mm, and add 10 times the thickness of ginger slices, eucommia ulmoides, and jujube with a thickness of 2 mm in the weight ratio. Decoct in heavy water twice, each time for 1.5 hours, combine the decoction, filter, concentrate the filtrate to a relative density of 1.05-1.10 (60°C), add ethanol to make the alcohol content 70% (w/w), let it stand Overnight, filter to obtain filtrate B, combine filtrate B and filtrate A, recover ethanol and concentrate to an appropriate amount, add appropriate amount of preservative and flavoring agent, adjust the total amount to 1000ml, stir well, filter, fill, and sterilize , to obtain oral liquid.

实施例5:制备本发明复方提取物及其软胶囊制剂Embodiment 5: Preparation of the compound extract of the present invention and its soft capsule preparation

称取原料药材吴茱萸9g、人参9g、泽泻9g,将所述重量配比的吴茱萸、人参、泽泻三味加10倍重量70%(v/v)的乙醇提取二次,每次1.5小时,滤过,合并滤液,得滤液A,备用;称取厚度为2mm的生姜片5g、杜仲15g、大枣7g,将所述重量配比的厚度为2mm的生姜片、杜仲、大枣加10倍重量水煎煮二次,每次1.5小时,合并煎液,滤过,滤液浓缩至相对密度为1.05-1.10(60℃),加入乙醇使含醇量为70%(w/w),静置过夜,滤过,得滤液B,将滤液B与滤液A合并,回收乙醇并浓缩至60℃时测相对密度为1.20-1.25的稠膏,减压干燥,粉碎成细粉;加植物油和蜂蜡组成的稀释剂,研匀,备用;另取明胶液(明胶100份,甘油50份,水120份)备用;在室温23±2℃、相对湿度40%的条件下,药液与明胶液压制成软胶囊,即得软胶囊制剂,植物油可以是大豆油、花生油、茶油中的一种或几种的混合油;也可将植物油换用为PEG400。Weigh 9 g of raw materials Evodia rutaecarpa, 9 g of ginseng, and 9 g of Alisma, and extract twice with ethanol of 10 times the weight of 70% (v/v) of Evodia rutaecarpa, ginseng, and Alisma eczema in the weight ratio, each time for 1.5 hours, Filtrate and combine the filtrates to obtain filtrate A, which is set aside; take 5 g of ginger slices, 15 g of eucommia ulmoides, and 7 g of jujube with a thickness of 2 mm, and add 10 times the thickness of ginger slices, eucommia ulmoides, and jujube with a thickness of 2 mm in the weight ratio. Decoct in heavy water twice, each time for 1.5 hours, combine the decoction, filter, concentrate the filtrate to a relative density of 1.05-1.10 (60°C), add ethanol to make the alcohol content 70% (w/w), let it stand Overnight, filter to get filtrate B, combine filtrate B and filtrate A, recover ethanol and concentrate to 60°C to measure thick paste with relative density of 1.20-1.25, dry under reduced pressure, crush into fine powder; add vegetable oil and beeswax to form Grind the diluent evenly, and set aside; take another gelatin solution (100 parts of gelatin, 50 parts of glycerin, and 120 parts of water) for use; under the conditions of room temperature 23±2°C and relative humidity of 40%, the liquid medicine and gelatin are hydraulically prepared Soft capsules, that is, soft capsule preparations, the vegetable oil can be one or a mixture of soybean oil, peanut oil, and camellia oil; the vegetable oil can also be replaced with PEG400.

实施例6:制备本发明复方提取物及其滴丸剂Embodiment 6: preparation compound extract of the present invention and dropping pill thereof

称取原料药材吴茱萸9g、人参9g、泽泻9g,将所述重量配比的吴茱萸、人参、泽泻三味加10倍重量70%(v/v)的乙醇提取二次,每次1.5小时,滤过,合并滤液,得滤液A,备用;称取厚度为2mm的生姜片5g、杜仲15g、大枣7g,将所述重量配比的厚度为2mm的生姜片、杜仲、大枣加10倍重量水煎煮二次,每次1.5小时,合并煎液,滤过,滤液浓缩至相对密度为1.05-1.10(60℃),加入乙醇使含醇量为70%(w/w),静置过夜,滤过,得滤液B,将滤液B与滤液A合并,回收乙醇并浓缩至60℃时测相对密度为1.20-1.25的稠膏,减压干燥,粉碎成细粉;加入适量的聚乙二醇4000,加热拌匀后,滴入另一种不相混溶的冷却液二甲基硅油中,滴制成丸,即得滴丸剂。此聚乙二醇4000可换用为聚氧乙烯(40)单硬脂酸酯,二甲基硅油冷却液可换用为液体石蜡或植物油中的任意一种。Weigh 9 g of raw materials Evodia rutaecarpa, 9 g of ginseng, and 9 g of Alisma, and extract twice with ethanol of 10 times the weight of 70% (v/v) of Evodia rutaecarpa, ginseng, and Alisma eczema in the weight ratio, each time for 1.5 hours, Filtrate and combine the filtrates to obtain filtrate A, which is set aside; take 5 g of ginger slices, 15 g of eucommia ulmoides, and 7 g of jujube with a thickness of 2 mm, and add 10 times the thickness of ginger slices, eucommia ulmoides, and jujube with a thickness of 2 mm in the weight ratio. Decoct in heavy water twice, each time for 1.5 hours, combine the decoction, filter, concentrate the filtrate to a relative density of 1.05-1.10 (60°C), add ethanol to make the alcohol content 70% (w/w), let it stand Overnight, filter to obtain filtrate B, combine filtrate B and filtrate A, recover ethanol and concentrate to 60°C to measure a thick paste with a relative density of 1.20-1.25, dry under reduced pressure, and pulverize into fine powder; add appropriate amount of polyethylene Glycol 4000, after heating and mixing well, drop into another immiscible cooling liquid, simethicone, and drop into pills to obtain drop pills. The polyethylene glycol 4000 can be replaced with polyoxyethylene (40) monostearate, and the simethicone coolant can be replaced with any one of liquid paraffin or vegetable oil.

实施例7:制备本发明复方提取物及其丸剂Embodiment 7: preparation compound extract of the present invention and pill thereof

称取原料药材吴茱萸9g、人参9g、泽泻9g,将所述重量配比的吴茱萸、人参、泽泻三味加10倍重量70%(v/v)的乙醇提取二次,每次1.5小时,滤过,合并滤液,得滤液A,备用;称取厚度为2mm的生姜片5g、杜仲15g、大枣7g,将所述重量配比的厚度为2mm的生姜片、杜仲、大枣加10倍重量水煎煮二次,每次1.5小时,合并煎液,滤过,滤液浓缩至相对密度为1.05-1.10(60℃),加入乙醇使含醇量为70%(w/w),静置过夜,滤过,得滤液B,将滤液B与滤液A合并,回收乙醇并浓缩至60℃时测相对密度为1.20-1.25的稠膏,减压干燥,粉碎成细粉,过60目的筛网;加入炼蜜和药,制成蜜丸,即得丸剂。Weigh 9 g of raw materials Evodia rutaecarpa, 9 g of ginseng, and 9 g of Alisma, and extract twice with ethanol of 10 times the weight of 70% (v/v) of Evodia rutaecarpa, ginseng, and Alisma eczema in the weight ratio, each time for 1.5 hours, Filtrate and combine the filtrates to obtain filtrate A, which is set aside; take 5 g of ginger slices, 15 g of eucommia ulmoides, and 7 g of jujube with a thickness of 2 mm, and add 10 times the thickness of ginger slices, eucommia ulmoides, and jujube with a thickness of 2 mm in the weight ratio. Decoct in heavy water twice, each time for 1.5 hours, combine the decoction, filter, concentrate the filtrate to a relative density of 1.05-1.10 (60°C), add ethanol to make the alcohol content 70% (w/w), let it stand Overnight, filter to obtain filtrate B, combine filtrate B and filtrate A, recover ethanol and concentrate to 60°C to measure a thick paste with a relative density of 1.20-1.25, dry under reduced pressure, crush into fine powder, and pass through a 60-mesh sieve ; Add refined honey and medicine to make honeyed pills, that is, pills.

Claims (6)

1、一种治疗高血压病的中药制剂,其特征在于:按照重量组分计,由吴茱萸3-12份,人参3-12份,泽泻3-12份,杜仲10-20份,生姜2-15份和大枣5-20份以及适量的辅料制备而成。1. A traditional Chinese medicine preparation for treating hypertension, characterized in that: according to weight components, it consists of 3-12 parts of Evodia rutaecarpa, 3-12 parts of ginseng, 3-12 parts of Alisma, 10-20 parts of Eucommia, and 2 parts of ginger. -15 parts, 5-20 parts of jujube and appropriate auxiliary materials. 2、根据权利要求1所述的治疗高血压病的中药制剂,其特征在于:由吴茱萸9g,人参9g,泽泻9g,杜仲15g,生姜5g和大枣7g加适量的辅料制备而成。2. The traditional Chinese medicine preparation for treating hypertension according to claim 1, characterized in that it is prepared from 9g of Evodia rutaecarpa, 9g of ginseng, 9g of Alisma, 15g of Eucommia ulmoides, 5g of ginger and 7g of jujube plus appropriate amount of auxiliary materials. 3、根据权利要求1或2所述的治疗高血压病的中药制剂,其特征在于所述的中药制剂是:颗粒制剂、胶囊制剂、片剂、丸剂、或口服液制剂。3. The traditional Chinese medicine preparation for treating hypertension according to claim 1 or 2, characterized in that said traditional Chinese medicine preparation is: granule preparation, capsule preparation, tablet, pill or oral liquid preparation. 4、根据权利要求3所述的治疗高血压病的中药制剂,其特征在于所述的中药制剂是颗粒制剂。4. The traditional Chinese medicine preparation for treating hypertension according to claim 3, characterized in that said traditional Chinese medicine preparation is a granule preparation. 5、根据权利要求1-4中任意一项所述治疗高血压病的中药制剂的制备方法,其特征在于:称取原料药材吴茱萸、人参和泽泻,将吴茱萸、人参和泽泻加8-20倍重量的体积比为50-80%的乙醇提取1-5次,每1-2小时,滤过,得滤液A备用;将切成厚度为1-8毫米的生姜、杜仲和大枣加8-20倍重量水,提取时间1-4小时,共提1-4次,合并煎液,滤过,滤液浓缩至一定的相对密度的清膏,放冷,加乙醇使药液含醇量为重量比50-80%,静置10-24小时,滤过,得滤液B,将滤液A与滤液B合并,回收乙醇并浓缩至一定密度的稠膏,干燥,粉碎成细粉;加入辅料适量,制备成需要的制剂。5. The preparation method of the traditional Chinese medicine preparation for treating hypertension according to any one of claims 1-4, characterized in that: taking the raw materials Evodia rutaecarpa, ginseng and Alisma, adding 8- The volume ratio of 20 times the weight is 50-80% ethanol extraction 1-5 times, every 1-2 hours, filter, and get the filtrate A for subsequent use; Ginger, Eucommia and jujube that are cut into 1-8 mm in thickness are added 8-20 times the weight of water, the extraction time is 1-4 hours, a total of 1-4 times, the decoction is combined, filtered, the filtrate is concentrated to a certain relative density of clear paste, let it cool, add ethanol to increase the alcohol content of the liquid The weight ratio is 50-80%, standing for 10-24 hours, filtering to obtain filtrate B, combining filtrate A and filtrate B, recovering ethanol and concentrating to a thick paste with a certain density, drying, and pulverizing into fine powder; adding auxiliary materials Appropriate amount is prepared into required preparations. 6、按照权利要求5所述治疗高血压病的中药制剂的制备方法,其特征在于:称取原料药材吴茱萸9g、人参9g和泽泻9g加8-20倍重量的体积比为50-80%的乙醇提取1-5次,每1-2小时,滤过,得滤液A备用;将切成厚度为1-8毫米的生姜片5g、杜仲15g和大枣7g加8-20倍重量水,提取时间1-4小时,共提1-4次,合并煎液,滤过,滤液浓缩至一定的相对密度的清膏,放冷,加乙醇使药液含醇量为重量比50-80%,静置10-24小时,滤过,得滤液B,将滤液A与滤液B合并,回收乙醇并浓缩至一定密度的稠膏,干燥,粉碎成细粉;加入辅料适量,混匀,制成颗粒1000g,得颗粒剂。6. According to the preparation method of the traditional Chinese medicine preparation for treating hypertension according to claim 5, it is characterized in that: the volume ratio of weighing 9g of raw materials Evodia rutaecarpa, 9g of ginseng and 9g of Alisma 9g plus 8-20 times the weight is 50-80% Extract 1-5 times with ethanol, and filter every 1-2 hours to obtain filtrate A for subsequent use; add 8-20 times the weight of water to 5 g of ginger slices, 15 g of Eucommia ulmoides and 7 g of jujube cut into 1-8 mm in thickness, The extraction time is 1-4 hours, and a total of 1-4 times is extracted, the decoction is combined, filtered, the filtrate is concentrated to a certain relative density of clear paste, let it cool, and ethanol is added to make the alcohol content of the liquid medicine 50-80% by weight , stand still for 10-24 hours, filter to obtain filtrate B, combine filtrate A and filtrate B, recover ethanol and concentrate to a thick paste with a certain density, dry, and pulverize into fine powder; add appropriate amount of auxiliary materials, mix well, and make 1000g of granules to obtain granules.
CNB2006100868467A 2006-06-21 2006-06-21 Chinese-medicinal preparation for treating hypertension and its making method Expired - Fee Related CN100435842C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2006100868467A CN100435842C (en) 2006-06-21 2006-06-21 Chinese-medicinal preparation for treating hypertension and its making method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2006100868467A CN100435842C (en) 2006-06-21 2006-06-21 Chinese-medicinal preparation for treating hypertension and its making method

Publications (2)

Publication Number Publication Date
CN1895659A CN1895659A (en) 2007-01-17
CN100435842C true CN100435842C (en) 2008-11-26

Family

ID=37608403

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2006100868467A Expired - Fee Related CN100435842C (en) 2006-06-21 2006-06-21 Chinese-medicinal preparation for treating hypertension and its making method

Country Status (1)

Country Link
CN (1) CN100435842C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6243686B2 (en) * 2013-09-30 2017-12-06 小林製薬株式会社 An oral composition containing a processed product and a processed product of ginger, and a method for enhancing the scent of the product

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1772133A (en) * 2005-10-27 2006-05-17 杨文琳 Hypertension treating capsule

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1772133A (en) * 2005-10-27 2006-05-17 杨文琳 Hypertension treating capsule

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
吴茱萸汤证探究. 张长恩.北京中医,第2期. 1993
吴茱萸汤证探究. 张长恩.北京中医,第2期. 1993 *

Also Published As

Publication number Publication date
CN1895659A (en) 2007-01-17

Similar Documents

Publication Publication Date Title
CN103041118B (en) A composition with hypoglycemic and hypolipidemic effects
CN106975012B (en) Traditional Chinese medicine composition for reducing blood sugar and preparation method thereof
CN105362340B (en) A kind of pharmaceutical composition for treating leukaemia and preparation method thereof
CN101543248B (en) A cold tea especially suitable for &#39;three high and one acid&#39; population and method for preparing same
JP2002154979A (en) Pharmaceutical composition for type I allergy and method for producing the same
CN107890528B (en) Traditional Chinese medicine composition for treating hyperuricemia and preparation method thereof
CN1171624C (en) Method for preparing Chinese medicine Liuwei Dihuang preparation
CN102441064B (en) Traditional Chinese medicine composition and its preparation for treating diabetes
CN100435842C (en) Chinese-medicinal preparation for treating hypertension and its making method
CN103385931A (en) Blood-sugar-lowering medicine composition
CN107029124B (en) Traditional Chinese medicine composition for treating primary hypertension and preparation method thereof
US7179492B2 (en) Traditional chinese pharmaceutical formulation for treatment of paradentosis&amp;comma; process for preparation and use thereof
CN101172155A (en) New formulation of pulse-activating gallbladder-warming decoction and production method thereof
CN104524359B (en) A kind of Chinese medicine composition, its preparation method and application
CN100396279C (en) A kind of traditional Chinese medicine preparation for treating arrhythmia and preparation method thereof
CN105169187B (en) A kind of composition and its application, preparation method and drug, food containing the composition
CN103721074B (en) Pharmaceutical composition and preparation method and application thereof
CN103989940A (en) Traditional Chinese medicine composition for treating diabetes mellitus
CN113995782B (en) Application of composition containing selfheal to preparation of medicine for treating thyroid nodules
CN114848764B (en) Traditional Chinese medicine compound composition for preventing and treating liver injury and preparation method and application thereof
CN104173886B (en) A kind of granule for treating senile hyperthyroidism and its preparation method
CN111569012B (en) Traditional Chinese medicine composition for treating sepsis myocardial injury and preparation method thereof
CN101554399B (en) Psoralea corylifolial extract with immunologic enhancement and application thereof
CN100355440C (en) Compound Chinese medicinal preparation for treating type II diabetes and lowering blood sugar and its preparation method
CN100525786C (en) Compound milettia reticulata capsule and method for preparing the same

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Zhang Liyan

Document name: Notice of application for publication of patent for invention and entry into the substantive examination procedure

C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20081126

Termination date: 20110621